NANOG and neoplasm: Thus, it is possible that specific tumor cells that did not express NANOG underwent cell death, while undifferentiated tumor cells, including CSCs overexpressing NANOG, survived and continued to proliferate in patients who underwent preoperative adjuvant therapy.